EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma

Yen-Nhi Ngoc Ta, Van-Anh Thi Nguyen, Thu-Thuy Can, Meng-Cheng Hsieh, Bang Giang Thi Cao, Dehui Wan iD, Chian-Hui Lai iD, Chun-Chieh Wu, Fu-Fei Hsu, Yu-Ting Yen, Shen-Nien Wang, Yunching Chen iD

ACS Nano · 20.01.2026 · 20 (2) · 1870-1884

DOI: 10.1021/acsnano.5c11352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 06.01.2026. Verfasst von Yen-Nhi Ngoc Ta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Drug Resistance, Neoplasm, Glucose Oxidase. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Research Institutes, National Tsing Hua University, China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDrug Resistance, NeoplasmGlucose OxidaseAntineoplastic AgentsAnimalsHumansMiceDoxorubicinApoptosisCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

glucose oxidase (GOx)glycolysishepatocellular carcinoma (HCC)immunometabolismimmunotherapypH-responsive enzyme delivery

Substanzen

DoxorubicinGlucose OxidaseAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan.
  • International Intercollegiate PhD Program, National Tsing Hua University, Hsinchu 30013, Taiwan.
  • Graduate Institute of Biomedical Engineering, National Chung Hsing University, Taichung 40227, Taiwan.
  • Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
  • Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
  • Institute of Translational Medicine and New Drug Development, School of Medicine, China Medical University, Taichung 40402, Taiwan.

ORCID-Profile: Dehui Wan, Chian-Hui Lai, Yunching Chen

Förderung

  • National Health Research Institutes
  • National Tsing Hua University
  • China Medical University
  • Kaohsiung Medical University Chung-Ho Memorial Hospital
  • National Science and Technology Council

Zitieren

APA

Ta, Y. N., Nguyen, V. T., Can, T. T., Hsieh, M. C., Cao, B. G. T., Wan, D., Lai, C. H., Wu, C. C., Hsu, F. F., Yen, Y. T., Wang, S. N., & Chen, Y. (2026). Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma. ACS Nano, 20(2), 1870-1884. https://doi.org/10.1021/acsnano.5c11352

Vancouver

Ta YN, Nguyen VT, Can TT, Hsieh MC, Cao BGT, Wan D, et al. Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma. ACS Nano. 2026;20(2):1870-1884. doi:10.1021/acsnano.5c11352

BibTeX
@article{Ta2026,
  author = {Ta, Yen-Nhi Ngoc and Nguyen, Van-Anh Thi and Can, Thu-Thuy and Hsieh, Meng-Cheng and Cao, Bang Giang Thi and Wan, Dehui and Lai, Chian-Hui and Wu, Chun-Chieh and Hsu, Fu-Fei and Yen, Yu-Ting and Wang, Shen-Nien and Chen, Yunching},
  title = {Stimuli-Responsive Nanozyme Reprograms Tumor Immunometabolism and Overcomes Therapeutic Resistance in Hepatocellular Carcinoma},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {1870--1884},
  doi = {10.1021/acsnano.5c11352}
}
Kostenlos starten →